Digitek Recall

Digitek is a medication that is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Because patients prescribed Digitek are already under a physician’s care for heart troubles, an incorrect dosage of this medication can be especially dangerous, creating even more cardiac instability and compounding existing problems.

April 25, 2008, Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, initiated a Class I nationwide recall of Digitek (digoxin tablets, USP, all strengths) for oral use. The Digitek recall was initiated after it was learned that tablets contained twice the level of the active ingredient. The recalled products were distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc. under a “UDL” label.

Taking more than the safe level of Digitek can lead to digitalis toxicity. Digitalis toxicity can lead to nausea, vomiting, dizziness, low blood pressure, cardiac instability and even death.

Digitalis toxicity can occur from a single exposure or chronic overmedication, or it may occur in patients with normal blood levels of digitalis if other risks are present. People with heart failure are commonly given diuretics (medications used to pull excess fluid from the body) along with digoxin. Many diuretics can cause potassium loss. Low levels of potassium in the body increase the risk of digitalis toxicity.

Beasley Allen law firm pursued Digitek recall and digitalis toxicity claims in all 50 states. Our defective drug and product liability lawyers work solely on behalf of individual plaintiffs that were injured by defective medical devices and dangerous drugs, such as Digitek.

For more than 30 years, we have successfully handled thousands of defective drug claims, and have recovered more than $21 billion in verdicts and settlements for our clients.